Recent Company News

• 10:35 AM ET Apr 29, 2026
  

  Transcript Intelligence: PureTech Health Q4 Earnings Themes

• 10:35 AM ET Apr 29, 2026
  

  Transcript Intelligence: PureTech Health Q4 Earnings Guidance

• 10:34 AM ET Apr 29, 2026
  

  Transcript Intelligence: PureTech Health Q4 Earnings Q&A

• 04:15 AM ET Apr 13, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:19 AM ET Apr 29, 2026
  

  PureTech Health reports FY net income ($109.7M) vs FactSet ($149.1M) [1 est] (130.0000p, 0)

• 02:14 AM ET Apr 29, 2026
  

  PureTech Health intends to voluntarily delist its American Depositary Shares from Nasdaq; LSE will remain primary trading venue (130.0000p, 0)

• 07:06 AM ET Apr 22, 2026
  

  PureTech Health announces positive topline data from completed Phase 1B clinical trial of LYT-200 (130.0000p, -1)

• 04:16 PM ET Apr 10, 2026
  

  Follow-up: Seaport Therapeutics files for Nasdaq IPO of indeterminate size - S-1

• 08:14 AM ET Apr 02, 2026
  

  PureTech Health announces publication of phase 2b elevate IPF trial results in The American Journal of Respiratory and Critical Care Medicine (112.0000p, +2)